An Integrated Chemo-enzymatic Route for Preparation of β-Thymidine, a Key Intermediate in the Preparation of Antiretrovirals

A chemo-enzymatic method for production of β-thymidine, an intermediate in the synthesis of antiretrovirals, is described. Guanosine and thymine were converted by means of enzymatic transglycosylation to yield 5-methyluridine (5-MU), which was reproducibly synthesised at a 10−20-L scale in 85% yield...

Full description

Saved in:
Bibliographic Details
Published in:Organic process research & development 2011-01, Vol.15 (1), p.258-265
Main Authors: Gordon, Gregory E. R, Bode, Moira L, Visser, Daniel F, Lepuru, M. Jerry, Zeevaart, Jacob G, Ragubeer, Nasheen, Ratsaka, Molala, Walwyn, David R, Brady, Dean
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A chemo-enzymatic method for production of β-thymidine, an intermediate in the synthesis of antiretrovirals, is described. Guanosine and thymine were converted by means of enzymatic transglycosylation to yield 5-methyluridine (5-MU), which was reproducibly synthesised at a 10−20-L scale in 85% yield at a final product concentration of ∼80 g·L−1. A downstream processing (DSP) protocol was designed to remove reaction components interfering with the subsequent synthetic step. The crystallised 5-MU produced in the biocatalytic reaction was found to behave similarly to commercially available 5-MU, and the integration of the initial biocatalytic and subsequent three-step chemical process to β-thymidine was successfully demonstrated at bench scale.
ISSN:1083-6160
1520-586X
DOI:10.1021/op100208x